CF
JNP

Centaurus Financial’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Centaurus Financial’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,300
Closed -$29K – 2442
2018
Q2 		$29K Buy
+3,300
New +$29.7K ﹤0.01% 1135

Centaurus Financial's JNP Position: Q3 2018 in Review

Centaurus Financial sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 3,300 shares — an estimated $29K sold.

Centaurus Financial first reported a position in JNP in Q2 2018 and held it in 1 quarter. The position peaked at $29K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

  • Centaurus Financial reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Centaurus Financial sold 3,300 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $29K.
  • Centaurus Financial first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Centaurus Financial's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $29K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.